Alnylam Pharmaceuticals shares owned by Dodge & Cox
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Dodge & Cox
from 13F filings
Historical chart of Dodge & Cox investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Dodge & Cox consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Dodge & Cox
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $703M | 3.7M | 191.41 |
| 2023-09-30 | $664M | 3.7M | 177.10 |
| 2023-06-30 | $720M | 3.8M | 189.94 |
| 2023-03-31 | $780M | 3.9M | 200.32 |
| 2022-12-31 | $1.1B | 4.6M | 237.65 |
| 2022-09-30 | $979M | 4.9M | 200.16 |
| 2022-06-30 | $767M | 5.3M | 145.85 |
| 2022-03-31 | $894M | 5.5M | 163.29 |
| 2021-12-31 | $921M | 5.4M | 169.58 |
| 2021-09-30 | $1.0B | 5.4M | 188.81 |
| 2021-06-30 | $918M | 5.4M | 169.52 |
| 2021-03-31 | $610M | 4.3M | 141.19 |
| 2020-12-31 | $603M | 4.6M | 129.97 |
| 2020-09-30 | $681M | 4.7M | 145.60 |
| 2020-06-30 | $697M | 4.7M | 148.11 |
| 2020-03-31 | $554M | 5.1M | 108.85 |
| 2019-12-31 | $605M | 5.3M | 115.17 |
| 2019-09-30 | $427M | 5.3M | 80.42 |
| 2019-06-30 | $380M | 5.2M | 72.56 |
| 2019-03-31 | $467M | 5.0M | 93.45 |
| 2018-12-31 | $342M | 4.7M | 72.91 |
| 2018-09-30 | $408M | 4.7M | 87.52 |
| 2018-06-30 | $458M | 4.7M | 98.49 |
| 2018-03-31 | $559M | 4.7M | 119.10 |
| 2017-12-31 | $1.0B | 8.2M | 127.05 |
| 2017-09-30 | $1.1B | 9.1M | 117.49 |
| 2017-06-30 | $733M | 9.2M | 79.76 |
| 2017-03-31 | $482M | 9.4M | 51.25 |
| 2016-12-31 | $345M | 9.2M | 37.44 |
| 2016-09-30 | $358M | 5.3M | 67.78 |
| 2016-06-30 | $140M | 2.5M | 55.49 |